EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS IN REAL CLINICAL PRACTICE
Objective: to evaluate the clinical efficacy and safety of the targeted synthetic disease-modifying anti-rheumatic drug (DMARD) tofacitinib (TOFA; Yakvinus®) in patients with active psoriatic arthritis (PsA) at 12 and 24 weeks after starting treatment. To define the place of TOFA in the therapy of P...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Russo |
| Veröffentlicht: |
IMA PRESS LLC
2020-06-01
|
| Schriftenreihe: | Научно-практическая ревматология |
| Schlagworte: | |
| Online-Zugang: | https://rsp.mediar-press.net/rsp/article/view/2892 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|